| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/06/2004 | EP1414963A2 Lipid-associated molecules |
| 05/06/2004 | EP1414958A1 Method for gene expression |
| 05/06/2004 | EP1414948A2 Inhibition of apoptosis process and improvement of cell performance |
| 05/06/2004 | EP1414866A2 Fgf-affinity chromatography |
| 05/06/2004 | EP1414861A2 Humanized antibodies against icam-1, their production and uses |
| 05/06/2004 | EP1414860A2 Pan-specific monoclonal antibody |
| 05/06/2004 | EP1414858A2 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 05/06/2004 | EP1414857A1 Factor viii separation |
| 05/06/2004 | EP1414852A2 Human secreted proteins, their encoding pulynucleotides, and uses thereof |
| 05/06/2004 | EP1414850A2 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof |
| 05/06/2004 | EP1414495A1 Anti-microbial targeting chimeric pharmaceutical |
| 05/06/2004 | EP1414494A1 Inhibitors of her3 activity |
| 05/06/2004 | EP1414477A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP1352085A4 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 05/06/2004 | EP1007647B1 High level of expression of ingap |
| 05/06/2004 | EP0889955B1 Recombinant phages |
| 05/06/2004 | EP0819173B1 Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases |
| 05/06/2004 | EP0729297A4 Hepatoblasts and method of isolating same |
| 05/06/2004 | CA2503437A1 High expression locus vector based on ferritin heavy chain gene locus |
| 05/06/2004 | CA2503315A1 Procedure for obtaining cell lines in a protein-free media and cell line obtained by the method |
| 05/06/2004 | CA2503026A1 Antibody and utilization of the same |
| 05/05/2004 | CN1494593A Modified ciliary neurotrophic factor (CNTF) with reduced immunogenicity |
| 05/05/2004 | CN1494591A Polynucleotide useful for modulating cancer cell proliferation |
| 05/05/2004 | CN1494590A Modified thrombopoietin with reduced immunogenicity |
| 05/05/2004 | CN1494589A 方法 Method |
| 05/05/2004 | CN1494553A Modified antibodies and method of use |
| 05/05/2004 | CN1494430A Modified protamine with reduced immunogenicity |
| 05/05/2004 | CN1493693A Mammal cell expression system and its application |
| 05/05/2004 | CN1493597A Separation dendron shaped cell membrane protein gene |
| 05/05/2004 | CN1493596A Polypeptide-human programming cell death protein 22 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493595A Polypeptide-human tumour protein 20 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493594A Polypeptide-human signal peptide secretory protein I 10 and polynucleolide for coding said polypeptide |
| 05/05/2004 | CN1493593A Polypeptide-human transcription regulate and control protein 44 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493592A Polypeptide-respiratory protein 18 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493591A Polypeptide-human protein synthetic protein L14, 22 and nucleotide for coding said polypeptide |
| 05/05/2004 | CN1493590A Polypeptide-human cell disintegrate regulatory protein 27 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493589A Polypeptide-human cell regulate and control protein 54 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493588A Polyepeptide-human transcription regulate and control protein 35 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493587A Polypeptide-human protein regulatory protein s9 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493586A Polypeptide-human transcription regulate and control protein 38 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493585A Polypeptide-human tubulin monomer releasing factor 28 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493584A New polypeptide-human tumour inhibiting factor 46 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493583A New polypeptide-hyman glucoprotein 42 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1148577C Antibodies and SCFV immunotoxins specific to improted fire ants, and their application |
| 05/05/2004 | CN1148450C Recombinant proteinse of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |
| 05/05/2004 | CN1148448C DNA for coding complete malaria antigene gp 190/MSP1, preparing process and use thereof |
| 05/05/2004 | CN1148447C Amino-terminally trancated RANTES as chemokine antagonists |
| 05/05/2004 | CN1148382C Cathepsin O2 protease |
| 05/04/2004 | US6730778 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 05/04/2004 | US6730776 An antimicrobial compound produced by culturing and deacylating in the presence a microbial substance; used for treatment of infectious diseases caused by pathogenic microorganisms such as yeast or fungi |
| 05/04/2004 | US6730658 Stimulation of lymphatic growth with an FLT4 ligand |
| 05/04/2004 | US6730504 Bacillus natto culture extract |
| 05/04/2004 | US6730489 Antibodies to truncated VEGF-D and uses thereof |
| 05/04/2004 | US6730488 Immunoassay for detecting preferential enzymatic polypeptide in sample |
| 05/04/2004 | US6730486 Human βTrCP protein |
| 05/04/2004 | US6730483 Phagemid for antibody screening |
| 05/04/2004 | US6730480 Sphingosine kinase enzyme |
| 05/04/2004 | US6730306 Plant antigens |
| 05/04/2004 | US6730304 Viral nuceotide sequences for use in the diagnosis of viral diseases |
| 05/04/2004 | US6730301 Mediating chemotaxis and activation of monocytes; athero-sclerosis; monocyte chemoattractant protein-1 (mcp-1) |
| 05/04/2004 | US6730300 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 05/04/2004 | CA2170885C Process for the purification of basic fibroblast growth factor |
| 05/04/2004 | CA2110442C Process for obtaining proinsulin possessing correctly linked cystine bridges |
| 05/04/2004 | CA2080226C Cd4-gamma2 and cd4-igg2 chimeras |
| 04/29/2004 | WO2004036258A2 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 04/29/2004 | WO2004036257A2 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 04/29/2004 | WO2004035802A1 Protein modification |
| 04/29/2004 | WO2004035777A1 Adipocyte differentiation-associated genes and proteins |
| 04/29/2004 | WO2004035772A1 Protein synthesis system using xenopus oocyte extract |
| 04/29/2004 | WO2004035764A2 PROTEIN SYNTHESIS WITH TANDEMLY ACTIVATED tRNAs |
| 04/29/2004 | WO2004035757A2 Protein synthesis using modified ribosomes |
| 04/29/2004 | WO2004035743A2 Site specific incorporation of keto amino acids into proteins |
| 04/29/2004 | WO2004035611A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 04/29/2004 | WO2004035605A2 Glycoprotein synthesis |
| 04/29/2004 | WO2004035070A1 Induction of gene expression using a high concentration sugar mixture |
| 04/29/2004 | WO2004035006A2 Methods and compositions for immunization against hiv |
| 04/29/2004 | WO2004034979A2 Monoclonal antibodies specific for cariogenic bacteria |
| 04/29/2004 | WO2004014311A3 Nogo receptor antagonists |
| 04/29/2004 | WO2003089622A3 Novel genes, compositions, and methods for modulating the unfolded protein response |
| 04/29/2004 | WO2003080796A9 Ordered biological nanostructures formed from chaperonin polypeptides |
| 04/29/2004 | WO2003065973A3 Multivalent streptococcal vaccine compositions and methods for use |
| 04/29/2004 | WO2003048187A3 Peptides and use thereof in therapeutic agents against hiv infection |
| 04/29/2004 | WO2003042399A9 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 04/29/2004 | WO2003010196A3 Variants and exons of the glyt1 transporter |
| 04/29/2004 | WO2003004683A3 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/29/2004 | WO2002072630A3 Nucleic acid-associated proteins |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002043651A8 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease |
| 04/29/2004 | US20040082773 Modified PAR receptors, their preparation and their uses for selecting compounds which modulate PAR activity |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/29/2004 | US20040082757 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs |
| 04/29/2004 | US20040082531 Containing a transcription regulatory sequence derived from Human Cytomegalovirus major immediate early gene that includes exon 1, but not intron A; use of such vectors in vaccine and pharmaceutical compositions and gene therapy |
| 04/29/2004 | US20040082506 For treating hypophosphatemic rickets/osteomalacia/ osteoporosis/renal osteodystrophy/dialysis-associated bone diseases |
| 04/29/2004 | US20040082054 Novel depsipeptide compound |
| 04/29/2004 | US20040082053 Thermostable glutaminase and thermostable glutaminase gene |
| 04/29/2004 | US20040082039 Immunoglobulin fusion proteins |
| 04/29/2004 | US20040082002 Genetic engineering; screening antagonist; medical diagnosis using antibodies |
| 04/29/2004 | US20040081999 Genetic engineered protein; controlling cell proliferation, cell differentiation |